Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene.

导出 LinkOut

翻译打印收藏纠错

第一作者： Pilar,Montero-Calle

第一单位： Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain.

作者： Pilar,Montero-Calle ^[1] ; María,Flandes-Iparraguirre ^[1] ; Bernd,Kuebler ^[2] ; Begoña,Arán ^[2] ; Eduardo,Larequi ^[3] ; Ilazki,Anaut ^[1] ; Giulia,Coppiello ^[1] ; Xabier L,Aranguren ^[1] ; Anna,Veiga ^[2] ; Maria Teresa Basurte,Elorz ^[4] ; Manuel García,de Yébenes ^[5] ; Juan J,Gavira ^[6] ; Felipe,Prósper ^[7] ; Olalla,Iglesias-García ^[8] ; Manuel M Mazo,Vega ^[9]

作者单位： Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain. ^[1] Barcelona Stem Cell Bank, Regenerative Medicine Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain. ^[2] Hematology and Cell Therapy, Clínica Universidad de Navarra, Pamplona, Spain. ^[3] Complejo Hospitalario de Navarra, Pamplona, Spain. ^[4] Department of Cardiology, Clínica Universidad de Navarra, Madrid, Spain. ^[5] Department of Cardiology, Clínica Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. ^[6] Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain; Hematology and Cell Therapy, Clínica Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. ^[7] Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. Electronic address: oiglesias@unav.es. ^[8] Regenerative Medicine Program, CIMA Universidad de Navarra, Pamplona, Spain; Hematology and Cell Therapy, Clínica Universidad de Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. Electronic address: mmazoveg@unav.es. ^[9]

主题词人类(Humans);前白蛋白(Prealbumin);诱导多能干细胞(Induced Pluripotent Stem Cells);白细胞, 单核(Leukocytes, Mononuclear);突变(Mutation);心肌疾病(Cardiomyopathies)

DOI 10.1016/j.scr.2023.103189

PMID 37660554

发布时间 2023-09-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Stem cell research

2023年71卷

103189页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene.

Stem cell research

相似文献

Stem cell research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene.

Stem cell research

相似文献

Stem cell research

相关期刊

检索历史清除